Literature DB >> 16888151

Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.

Patrick M Sexton1, Maria Morfis, Nanda Tilakaratne, Debbie L Hay, Madhara Udawela, George Christopoulos, Arthur Christopoulos.   

Abstract

The most well-characterized subgroup of family B G protein-coupledreceptors (GPCRs) comprises receptors for peptide hormones, such as secretin, calcitonin (CT), glucagon, and vasoactive intestinal peptide (VIP). Recent data suggest that many of these receptors can interact with a novel family of GPCR accessory proteins termed receptor activity modifying proteins (RAMPs). RAMP interaction with receptors can lead to a variety of actions that include chaperoning of the receptor protein to the cell surface as is the case for the calcitonin receptor-like receptor (CLR) and the generation of novel receptor phenotypes. RAMP heterodimerization with the CLR and related CT receptor is required for the formation of specific CT gene-related peptide, adrenomedullin (AM) or amylin receptors. More recent work has revealed that the specific RAMP present in a heterodimer may modulate other functions such as receptor internalization and recycling and also the strength of activation of downstream signaling pathways. In this article we review our current state of knowledge of the consequence of RAMP interaction with family B GPCRs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888151     DOI: 10.1196/annals.1317.076

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  31 in total

1.  Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.

Authors:  Margarita Ivanova; Stiliana Belcheva; Iren Belcheva; Negrin Negrev; Roman Tashev
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

Review 2.  Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors.

Authors:  Kuntal Pal; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

Review 3.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

Review 4.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

5.  Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

Review 6.  GPCR and G proteins: drug efficacy and activation in live cells.

Authors:  Jean-Pierre Vilardaga; Moritz Bünemann; Timothy N Feinstein; Nevin Lambert; Viacheslav O Nikolaev; Stefan Engelhardt; Martin J Lohse; Carsten Hoffmann
Journal:  Mol Endocrinol       Date:  2009-02-05

Review 7.  Endothelin receptors: what's new and what do we need to know?

Authors:  Stephanie W Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

8.  Rat intermedin1-47 does not improve functional recovery in postischemic hearts.

Authors:  Gerald Münzel; Alexander Schlier; Rolf Schreckenberg; Yaser Abdallah; Klaus-Dieter Schlüter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-01       Impact factor: 3.000

Review 9.  Mechanisms of multimodal sensing by extracellular Ca(2+)-sensing receptors: a domain-based survey of requirements for binding and signalling.

Authors:  Mahvash A Khan; Arthur D Conigrave
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

10.  Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.